"Worldwide Clinical Trials is a customer-centric Contract Research Organization (CRO) with over 30 years of experience of fostering the development of life-changing medicines by integrating clinical trial methodology, operational acumen, and efficient technology."

During the past decade, Worldwide Clinical Trials Early Phase Services conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Worldwide Clinical Trials Early Phase Services" #1 sponsor was "Daiichi Sankyo, Inc." with 1 trials, followed by "Mylan Pharma UK Ltd." with 1 trials sponsored, "Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc." with 1 trials sponsored, "ProJenX" with 1 trials sponsored and "Prothena Biosciences Limited" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Worldwide Clinical Trials Early Phase Services" #1 collaborator was "World Wide Clinical Trials Early Phase Services, LLC" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Worldwide Clinical Trials Early Phase Services" are "Amyotrophic Lateral Sclerosis" (1 trials), "Asthma" (1 trials), "COPD" (1 trials), "Healthy" (1 trials) and "Pharmacokinetics in Healthy Volunteers" (1 trials). Many other conditions were trialed in "Worldwide Clinical Trials Early Phase Services" in a lesser frequency.

Most popular intervention types in "Worldwide Clinical Trials Early Phase Services" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "14C PER977" (1 trials), "Advair® Diskus®" (1 trials), "MGR001" (1 trials), "PRX003" (1 trials) and "Pexidartinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Worldwide Clinical Trials Early Phase Services" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Worldwide Clinical Trials Early Phase Services". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Worldwide Clinical Trials Early Phase Services, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Worldwide Clinical Trials Early Phase Services, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".